Cardiac biosensors stand at the forefront of transformative healthcare technologies, revolutionizing the landscape of cardiovascular diagnostics and monitoring. These state-of-the-art biosensors employ sophisticated sensing mechanisms to identify specific biomarkers or physiological signals associated with cardiac health. The real-time and precise data provided by cardiac biosensors enable healthcare practitioners to make informed decisions promptly, ushering in a new era of personalized and responsive patient care. These biosensors are instrumental in the early identification, continuous monitoring, and effective management of cardiovascular conditions, significantly enhancing patient outcomes. As the field of biosensing technology evolves through ongoing research and development, the incorporation of cardiac biosensors promises to redefine the standards of cardiovascular healthcare, bringing forth a future where proactive and personalized cardiac monitoring becomes integral to the standard of care.
Title : Complete heart block and persistent left SVC: A pacing challenge after AV canal repair
Moataz Taha Mahmoud, Madinah Cardiac Center, Saudi Arabia
Title : Chemical detergent anionic surfactant-inducing dry cardiomyopathy (Yasser's cardiomyopathy) with parallel pupils/CXR phenomenon (Yasser's ophthalmic phenomenon), up-down Yasser's alternance, S1Q3 flat T3 pattern - Dramatic response to honey with possible cardiac regeneration - A case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt
Title : Stabilization of molecular structures in red blood cell membrane by magnetite nanoparticles (ICNB) during storage
Andrey Belousov, Laboratory of Applied Nanotechnology of Belousov and Kharkiv National Medical University, Ukraine